Theratechnologies shares surge 25% amid $254m Future Pak takeover
The acquisition will bring the Nasdaq-listed Theratechnologies back under private ownership.

The acquisition will bring the Nasdaq-listed Theratechnologies back under private ownership.
A sales rep looking up a healthcare professional's (HCP) contact details finds three records, each with conflicting information. At the same time, leadership struggles to generate accurate global reports due...
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Lisata collaborates with GATC Health on drug development
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI act
Next-generation targeting for evolving HCP engagement